Galectin Therapeutics Inc
GALT· Nasdaq
GALTGalectin Therapeutics Inc
Filed Aug 12, 2011 · 10-Q · 43 days after period end · 0001193125-11-220486
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Net Income | -$3.13M | -$1.65M |
| EPS Diluted | -$0.34 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Galectin Therapeutics Inc · CIK 1133416 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 12, 2011 · 43 d after period end
